Literature DB >> 17893259

Visceral adipose tissue zinc finger protein 36 mRNA levels are correlated with insulin, insulin resistance index, and adiponectinemia in women.

Luigi Bouchard1, Marie-Claude Vohl, Yves Deshaies, Caroline Rhéaume, Marleen Daris, André Tchernof.   

Abstract

INTRODUCTION: Adipose tissue is now recognized as an endocrine organ and secretes numerous molecules and proteins potentially involved in the physiopathology of the metabolic syndrome. Recently, we have determined the transcriptome of omental adipose tissue, leading to the identification of a new candidate gene for obesity-related metabolic complications, zinc finger protein 36 (ZFP36), which is known to down-regulate tumor necrosis factor-alpha TNF-alpha) expression.
OBJECTIVE: The objective of this study was to further examine the relationship between ZFP36 gene expression levels, obesity-related phenotypes, and adipokines.
METHODS: Abdominal subcutaneous and omental adipose tissue samples were obtained from 46 women undergoing elective gynecological surgery. Adipose tissue ZFP36 mRNA abundance was assessed by quantitative real-time PCR. Body fat accumulation and distribution were measured by dual X-ray absorptiometry and computed tomography. Fasting blood levels of glucose, insulin, and lipids, and circulating TNF-alpha, interleukin-6 (IL-6), resistin, and adiponectin were also measured.
RESULTS: No correlation was observed between s.c. ZFP36 mRNA levels and any of the phenotypes tested. However, although omental ZFP36 mRNA levels were not correlated with measures of body fatness and lipid profile, they were negatively correlated with fasting insulin levels (R = -0.31; P = 0.05), the insulin resistance index (HOMA-IR; R = -0.31; P = 0.05), and 2-h post-glucose insulinemia (R = -0.32; P = 0.05). Omental ZFP36 mRNA abundance was also positively correlated with adiponectinemia (R = 0.35; P = 0.03) but not with circulating TNF-alpha, IL-6, and resistin concentrations.
CONCLUSION: These results suggest that ZFP36 gene expression in omental adipose tissue, but not in abdominal s.c. fat, may offer partial protection against the development of insulin resistance and diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893259     DOI: 10.1530/EJE-07-0073

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  9 in total

1.  Low and high fat diets inconsistently induce obesity in C57BL/6J mice and obesity compromises n-3 fatty acid status.

Authors:  Diana L Tallman; Amy D Noto; Carla G Taylor
Journal:  Lipids       Date:  2009-06-03       Impact factor: 1.880

2.  The mRNA-binding protein Zfp36 is upregulated by β-adrenergic stimulation and represses IL-6 production in 3T3-L1 adipocytes.

Authors:  Pavna K Brahma; Huanchun Zhang; Betsy S Murray; Feng-jue Shu; Neil Sidell; Emre Seli; Caleb B Kallen
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

3.  Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes.

Authors:  Bolin Qin; Kiran S Panickar; Richard A Anderson
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

4.  mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.

Authors:  Huanchun Zhang; W Robert Taylor; Giji Joseph; Valentina Caracciolo; Donna M Gonzales; Neil Sidell; Emre Seli; Perry J Blackshear; Caleb B Kallen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

5.  Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli.

Authors:  Heping Cao; Rui Lin; Sanjukta Ghosh; Richard A Anderson; Joseph F Urban
Journal:  Biotechnol Prog       Date:  2008-02-27

Review 6.  When less is more: novel mechanisms of iron conservation.

Authors:  Marina Bayeva; Hsiang-Chun Chang; Rongxue Wu; Hossein Ardehali
Journal:  Trends Endocrinol Metab       Date:  2013-08-12       Impact factor: 12.015

7.  Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21.

Authors:  Konrad T Sawicki; Hsiang-Chun Chang; Jason S Shapiro; Marina Bayeva; Adam De Jesus; Brian N Finck; Jason A Wertheim; Perry J Blackshear; Hossein Ardehali
Journal:  JCI Insight       Date:  2018-07-12

8.  Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19.

Authors:  M Catherine DeSoto
Journal:  Brain Behav Immun       Date:  2020-07-15       Impact factor: 7.217

9.  Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance.

Authors:  Jie Cao; Jianchang Wei; Ping Yang; Tong Zhang; Zhuanpeng Chen; Feng He; Fang Wei; Huacui Chen; He Hu; Junbin Zhong; Zhi Yang; Wensong Cai; Wanglin Li; Qiang Wang
Journal:  Mol Cancer       Date:  2018-08-13       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.